[1]
“Could be FOXO3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?”, Clinics, vol. 78, p. 100155, Jan. 2023, doi: 10.1016/j.clinsp.2022.100155.